Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Too early to give specific response on COVID-19 vaccine supplies to other countries, says MEA

Too early to give specific response on COVID-19 vaccine supplies to other countries, says MEA

Photo Credit :

New Delhi [India], January 14 (ANI): India on Thursday said that the vaccination process is just starting in the country and it is too early to give a specific response on the COVID-19 vaccine supplies to other countries.
Ministry of External Affairs spokesperson Anurag Srivastava said at the regular media briefing that India is still assessing production schedules and availability.
He said Prime Minister Narendra Modi has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis.
"In so far as requests from countries for vaccines from India, you would recall that Prime Minister has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis," he said.
"As you know, the vaccination process is just starting in India. It is too early to give a specific response on the supplies to other countries as we are still assessing production schedules and availability to take decisions in this regard. This may take some time," he added.
He was asked about Brazil's health ministry sending a flight to airlift doses of AstraZeneca vaccine from India and the process to be adopted for export of vaccines.
India has given emergency use authorisation to two COVID-19 vaccines Covishield and Covaxin, both being manufactured in the country.
While Covishield has been developed by AstraZeneca and Oxford University, Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR.
The COVID-19 vaccination drive will start in the country from January 16. (ANI)

Disclaimer: The views expressed in the article above are those of the authors' and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.


Tags assigned to this article:
mea COVID-19 coronavirus vaccines supply Anurag Srivastava

ANI

ANI

More From The Author >>